Pune: A five-year-old boy battling brain encephalitis and multi-organ failure caused by chikungunya recovered after a nearly fortnight-long stay in a .

Vivacelle Bio, a late-stage biopharma company developing life-saving treatments for shock and trauma, today announced its support of the Sepsis Alliance in its mission to raise awareness and ...

The refractory cement market is essential for industries requiring materials that can withstand high temperatures, such as steel production, cement manufacturing, and petrochemicals. Driven by the ...

Regeneron is back with long-term follow-up for its LAG-3 inhibitor and PD-1 inhibitor combo in advanced melanoma, phase 1 ...

Oncternal Therapeutics, Inc. (Nasdaq: ONCT) (the “Company”) today announced its decision to discontinue its clinical trials evaluating ONCT-534, its dual action androgen receptor inhibitor for the ...

Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced or recurrent endometrial carcinoma who are candidates for systemic therapy, ...

The company said it will lay off approximately 37 percent of its workforce and stop all clinical development as it explores strategic alternatives.